Longitudinal Study of Prevalence of Sodium Abnormalities in Hospitalized Patients With COVID-19
Background: Sodium abnormalities (dysnatremia) are frequently observed in patients with community-acquired pneumonia and are associated with excess mortality. Data on the prevalence of hyponatremia and hypernatremia (serum sodium [Na] < 135 and > 145 mmol/L respectively) in patients with coron...
Gespeichert in:
Veröffentlicht in: | Journal of the Endocrine Society 2021-05, Vol.5 (Supplement_1), p.A630-A630 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | A630 |
---|---|
container_issue | Supplement_1 |
container_start_page | A630 |
container_title | Journal of the Endocrine Society |
container_volume | 5 |
creator | Tzoulis, Ploutarchos Waung, Julian Bagkeris, Emmanouil Hussein, Ziad Biddanda, Aiyappa Cousins, John Dewsnip, Alice Falayi, Kanoyin McCaughran, P W Mullins, Chloe Naeem, Ammara Nwokolo, Munachiso Quah, Helen Bitat, Syed Rabha Deyab, Eithar Ponnampalam, Swarupini Bouloux, Pierre-Marc Gilles Montgomery, Hugh Baldeweg, Stephanie |
description | Background: Sodium abnormalities (dysnatremia) are frequently observed in patients with community-acquired pneumonia and are associated with excess mortality. Data on the prevalence of hyponatremia and hypernatremia (serum sodium [Na] < 135 and > 145 mmol/L respectively) in patients with coronavirus disease 19 (COVID-19) are currently lacking. Methods: The aim of this study was to evaluate the prevalence and etiology of hyponatremia and hypernatremia at several timepoints during hospitalization of COVID-19 patients. This retrospective, longitudinal, observational study included all COVID-19 positive adult patients admitted to two London hospitals over an 8-week period (February to May 2020). Results: Clinic records were reviewed in 488 patients, 277 males (56.8%) and 211 females (43.2%), with a median age of 68 years. Comorbidities were documented in 79.6%, with the commonest being hypertension (45.7%), diabetes mellitus (25%), and chronic kidney disease (16.4%). Prior to admission, 25 patients (5.1%) had pre-existing chronic hyponatremia. At hospital presentation, median [Na] concentration was 137 mmol/L. Dysnatremia was present in 146 patients (29.9%), including 26 (5.3%) with hypernatremia and 120 (24.6%) with hyponatremia, of whom [Na] was 130-134 mmol/L in 90 (18.4%) and < 130 mmol/L in 30 (6.2%). Only 19% of patients with < 130 mmol/L underwent adequate laboratory assessment of the etiology of hyponatremia. Of those, based on a urinary sodium cut-off of 30 mmol/L, hyponatremia was classified as hypovolemia in 75% and non-hypovolemic in 25%. For the remaining hyponatremic cases, using 5 mmol/L as the cut-off value for plasma urea, 55.7% were classified as probable hypovolemic and 44.3% non-hypovolemic hyponatremia. There was an
upward trajectory of [Na] values during hospital stay with a median increase of 2 mmol/L in the first 48 hours following admission. On the fifth day of hospitalization, the prevalence was similar for hypernatremia and hyponatremia (13.8% and 14.1%, respectively). On the tenth day, hypernatremia was more common than hyponatremia (14.2% vs 10.2% respectively). Analysis of [Na] throughout the hospital stay defined four subgroups; 185 patients (37.9%) remained normonatremic throughout hospitalization; 180 (36.9%) had exposure to hyponatremia; 53 (10.9%) were exposed to hypernatremia; and 70 (14.3%) experienced both hypernatremia and hyponatremia. Conclusions: Hyponatremia, usually mild, was common at admission in Covid-19 positive |
doi_str_mv | 10.1210/jendso/bvab048.1284 |
format | Article |
fullrecord | <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8090725</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_8090725</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1444-9c7e2e34cec0b5f824dcf034b32419dd5243b048fb5c8736a274befab327b25b3</originalsourceid><addsrcrecordid>eNpVUNtqAjEQDaWFivUL-pIf2JrbdndfCmIvCoKCvTyG3FYju4kkq2C_vlmU0j7NmXOYMzMHgHuMHjDBaLwzTkc_lkchESsTV7IrMCCsIBmuCnL9B9-CUYw7hBCuKKsYGwC-8G5ju4O2TjRwncAJ-hqugjmKxjhl-m7ttT20cCKdD61obGdNhNbBmY972yXi22i4Eol2XYRfttvC6fJz_px23oGbWjTRjC51CD5eX96ns2yxfJtPJ4tMYcZYVqnCEEOZMgrJvC4J06pGlElKGK60zgmj_Xe1zFVZ0EdBCiZNLZJeSJJLOgRPZ9_9QbZGq3RJEA3fB9uKcOJeWP5fcXbLN_7IS1ShguTJgJ4NVPAxBlP_zmLE-5z5OWd-yZn3OdMf7pR19g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Longitudinal Study of Prevalence of Sodium Abnormalities in Hospitalized Patients With COVID-19</title><source>DOAJ Directory of Open Access Journals</source><source>Oxford Journals Open Access Collection</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Tzoulis, Ploutarchos ; Waung, Julian ; Bagkeris, Emmanouil ; Hussein, Ziad ; Biddanda, Aiyappa ; Cousins, John ; Dewsnip, Alice ; Falayi, Kanoyin ; McCaughran, P W ; Mullins, Chloe ; Naeem, Ammara ; Nwokolo, Munachiso ; Quah, Helen ; Bitat, Syed Rabha ; Deyab, Eithar ; Ponnampalam, Swarupini ; Bouloux, Pierre-Marc Gilles ; Montgomery, Hugh ; Baldeweg, Stephanie</creator><creatorcontrib>Tzoulis, Ploutarchos ; Waung, Julian ; Bagkeris, Emmanouil ; Hussein, Ziad ; Biddanda, Aiyappa ; Cousins, John ; Dewsnip, Alice ; Falayi, Kanoyin ; McCaughran, P W ; Mullins, Chloe ; Naeem, Ammara ; Nwokolo, Munachiso ; Quah, Helen ; Bitat, Syed Rabha ; Deyab, Eithar ; Ponnampalam, Swarupini ; Bouloux, Pierre-Marc Gilles ; Montgomery, Hugh ; Baldeweg, Stephanie</creatorcontrib><description>Background: Sodium abnormalities (dysnatremia) are frequently observed in patients with community-acquired pneumonia and are associated with excess mortality. Data on the prevalence of hyponatremia and hypernatremia (serum sodium [Na] < 135 and > 145 mmol/L respectively) in patients with coronavirus disease 19 (COVID-19) are currently lacking. Methods: The aim of this study was to evaluate the prevalence and etiology of hyponatremia and hypernatremia at several timepoints during hospitalization of COVID-19 patients. This retrospective, longitudinal, observational study included all COVID-19 positive adult patients admitted to two London hospitals over an 8-week period (February to May 2020). Results: Clinic records were reviewed in 488 patients, 277 males (56.8%) and 211 females (43.2%), with a median age of 68 years. Comorbidities were documented in 79.6%, with the commonest being hypertension (45.7%), diabetes mellitus (25%), and chronic kidney disease (16.4%). Prior to admission, 25 patients (5.1%) had pre-existing chronic hyponatremia. At hospital presentation, median [Na] concentration was 137 mmol/L. Dysnatremia was present in 146 patients (29.9%), including 26 (5.3%) with hypernatremia and 120 (24.6%) with hyponatremia, of whom [Na] was 130-134 mmol/L in 90 (18.4%) and < 130 mmol/L in 30 (6.2%). Only 19% of patients with < 130 mmol/L underwent adequate laboratory assessment of the etiology of hyponatremia. Of those, based on a urinary sodium cut-off of 30 mmol/L, hyponatremia was classified as hypovolemia in 75% and non-hypovolemic in 25%. For the remaining hyponatremic cases, using 5 mmol/L as the cut-off value for plasma urea, 55.7% were classified as probable hypovolemic and 44.3% non-hypovolemic hyponatremia. There was an
upward trajectory of [Na] values during hospital stay with a median increase of 2 mmol/L in the first 48 hours following admission. On the fifth day of hospitalization, the prevalence was similar for hypernatremia and hyponatremia (13.8% and 14.1%, respectively). On the tenth day, hypernatremia was more common than hyponatremia (14.2% vs 10.2% respectively). Analysis of [Na] throughout the hospital stay defined four subgroups; 185 patients (37.9%) remained normonatremic throughout hospitalization; 180 (36.9%) had exposure to hyponatremia; 53 (10.9%) were exposed to hypernatremia; and 70 (14.3%) experienced both hypernatremia and hyponatremia. Conclusions: Hyponatremia, usually mild, was common at admission in Covid-19 positive patients, while hypovolemic hyponatremia appeared to be the predominant etiology. During hospital stay, abnormal sodium concentration was recorded in more than two thirds of Covid-19 positive patients. The association of dysnatremia with the outcomes in hospitalized COVID-19 patients warrants further exploration.</description><identifier>ISSN: 2472-1972</identifier><identifier>EISSN: 2472-1972</identifier><identifier>DOI: 10.1210/jendso/bvab048.1284</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Neuroendocrinology and Pituitary</subject><ispartof>Journal of the Endocrine Society, 2021-05, Vol.5 (Supplement_1), p.A630-A630</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090725/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090725/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27923,27924,53790,53792</link.rule.ids></links><search><creatorcontrib>Tzoulis, Ploutarchos</creatorcontrib><creatorcontrib>Waung, Julian</creatorcontrib><creatorcontrib>Bagkeris, Emmanouil</creatorcontrib><creatorcontrib>Hussein, Ziad</creatorcontrib><creatorcontrib>Biddanda, Aiyappa</creatorcontrib><creatorcontrib>Cousins, John</creatorcontrib><creatorcontrib>Dewsnip, Alice</creatorcontrib><creatorcontrib>Falayi, Kanoyin</creatorcontrib><creatorcontrib>McCaughran, P W</creatorcontrib><creatorcontrib>Mullins, Chloe</creatorcontrib><creatorcontrib>Naeem, Ammara</creatorcontrib><creatorcontrib>Nwokolo, Munachiso</creatorcontrib><creatorcontrib>Quah, Helen</creatorcontrib><creatorcontrib>Bitat, Syed Rabha</creatorcontrib><creatorcontrib>Deyab, Eithar</creatorcontrib><creatorcontrib>Ponnampalam, Swarupini</creatorcontrib><creatorcontrib>Bouloux, Pierre-Marc Gilles</creatorcontrib><creatorcontrib>Montgomery, Hugh</creatorcontrib><creatorcontrib>Baldeweg, Stephanie</creatorcontrib><title>Longitudinal Study of Prevalence of Sodium Abnormalities in Hospitalized Patients With COVID-19</title><title>Journal of the Endocrine Society</title><description>Background: Sodium abnormalities (dysnatremia) are frequently observed in patients with community-acquired pneumonia and are associated with excess mortality. Data on the prevalence of hyponatremia and hypernatremia (serum sodium [Na] < 135 and > 145 mmol/L respectively) in patients with coronavirus disease 19 (COVID-19) are currently lacking. Methods: The aim of this study was to evaluate the prevalence and etiology of hyponatremia and hypernatremia at several timepoints during hospitalization of COVID-19 patients. This retrospective, longitudinal, observational study included all COVID-19 positive adult patients admitted to two London hospitals over an 8-week period (February to May 2020). Results: Clinic records were reviewed in 488 patients, 277 males (56.8%) and 211 females (43.2%), with a median age of 68 years. Comorbidities were documented in 79.6%, with the commonest being hypertension (45.7%), diabetes mellitus (25%), and chronic kidney disease (16.4%). Prior to admission, 25 patients (5.1%) had pre-existing chronic hyponatremia. At hospital presentation, median [Na] concentration was 137 mmol/L. Dysnatremia was present in 146 patients (29.9%), including 26 (5.3%) with hypernatremia and 120 (24.6%) with hyponatremia, of whom [Na] was 130-134 mmol/L in 90 (18.4%) and < 130 mmol/L in 30 (6.2%). Only 19% of patients with < 130 mmol/L underwent adequate laboratory assessment of the etiology of hyponatremia. Of those, based on a urinary sodium cut-off of 30 mmol/L, hyponatremia was classified as hypovolemia in 75% and non-hypovolemic in 25%. For the remaining hyponatremic cases, using 5 mmol/L as the cut-off value for plasma urea, 55.7% were classified as probable hypovolemic and 44.3% non-hypovolemic hyponatremia. There was an
upward trajectory of [Na] values during hospital stay with a median increase of 2 mmol/L in the first 48 hours following admission. On the fifth day of hospitalization, the prevalence was similar for hypernatremia and hyponatremia (13.8% and 14.1%, respectively). On the tenth day, hypernatremia was more common than hyponatremia (14.2% vs 10.2% respectively). Analysis of [Na] throughout the hospital stay defined four subgroups; 185 patients (37.9%) remained normonatremic throughout hospitalization; 180 (36.9%) had exposure to hyponatremia; 53 (10.9%) were exposed to hypernatremia; and 70 (14.3%) experienced both hypernatremia and hyponatremia. Conclusions: Hyponatremia, usually mild, was common at admission in Covid-19 positive patients, while hypovolemic hyponatremia appeared to be the predominant etiology. During hospital stay, abnormal sodium concentration was recorded in more than two thirds of Covid-19 positive patients. The association of dysnatremia with the outcomes in hospitalized COVID-19 patients warrants further exploration.</description><subject>Neuroendocrinology and Pituitary</subject><issn>2472-1972</issn><issn>2472-1972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVUNtqAjEQDaWFivUL-pIf2JrbdndfCmIvCoKCvTyG3FYju4kkq2C_vlmU0j7NmXOYMzMHgHuMHjDBaLwzTkc_lkchESsTV7IrMCCsIBmuCnL9B9-CUYw7hBCuKKsYGwC-8G5ju4O2TjRwncAJ-hqugjmKxjhl-m7ttT20cCKdD61obGdNhNbBmY972yXi22i4Eol2XYRfttvC6fJz_px23oGbWjTRjC51CD5eX96ns2yxfJtPJ4tMYcZYVqnCEEOZMgrJvC4J06pGlElKGK60zgmj_Xe1zFVZ0EdBCiZNLZJeSJJLOgRPZ9_9QbZGq3RJEA3fB9uKcOJeWP5fcXbLN_7IS1ShguTJgJ4NVPAxBlP_zmLE-5z5OWd-yZn3OdMf7pR19g</recordid><startdate>20210503</startdate><enddate>20210503</enddate><creator>Tzoulis, Ploutarchos</creator><creator>Waung, Julian</creator><creator>Bagkeris, Emmanouil</creator><creator>Hussein, Ziad</creator><creator>Biddanda, Aiyappa</creator><creator>Cousins, John</creator><creator>Dewsnip, Alice</creator><creator>Falayi, Kanoyin</creator><creator>McCaughran, P W</creator><creator>Mullins, Chloe</creator><creator>Naeem, Ammara</creator><creator>Nwokolo, Munachiso</creator><creator>Quah, Helen</creator><creator>Bitat, Syed Rabha</creator><creator>Deyab, Eithar</creator><creator>Ponnampalam, Swarupini</creator><creator>Bouloux, Pierre-Marc Gilles</creator><creator>Montgomery, Hugh</creator><creator>Baldeweg, Stephanie</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20210503</creationdate><title>Longitudinal Study of Prevalence of Sodium Abnormalities in Hospitalized Patients With COVID-19</title><author>Tzoulis, Ploutarchos ; Waung, Julian ; Bagkeris, Emmanouil ; Hussein, Ziad ; Biddanda, Aiyappa ; Cousins, John ; Dewsnip, Alice ; Falayi, Kanoyin ; McCaughran, P W ; Mullins, Chloe ; Naeem, Ammara ; Nwokolo, Munachiso ; Quah, Helen ; Bitat, Syed Rabha ; Deyab, Eithar ; Ponnampalam, Swarupini ; Bouloux, Pierre-Marc Gilles ; Montgomery, Hugh ; Baldeweg, Stephanie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1444-9c7e2e34cec0b5f824dcf034b32419dd5243b048fb5c8736a274befab327b25b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Neuroendocrinology and Pituitary</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tzoulis, Ploutarchos</creatorcontrib><creatorcontrib>Waung, Julian</creatorcontrib><creatorcontrib>Bagkeris, Emmanouil</creatorcontrib><creatorcontrib>Hussein, Ziad</creatorcontrib><creatorcontrib>Biddanda, Aiyappa</creatorcontrib><creatorcontrib>Cousins, John</creatorcontrib><creatorcontrib>Dewsnip, Alice</creatorcontrib><creatorcontrib>Falayi, Kanoyin</creatorcontrib><creatorcontrib>McCaughran, P W</creatorcontrib><creatorcontrib>Mullins, Chloe</creatorcontrib><creatorcontrib>Naeem, Ammara</creatorcontrib><creatorcontrib>Nwokolo, Munachiso</creatorcontrib><creatorcontrib>Quah, Helen</creatorcontrib><creatorcontrib>Bitat, Syed Rabha</creatorcontrib><creatorcontrib>Deyab, Eithar</creatorcontrib><creatorcontrib>Ponnampalam, Swarupini</creatorcontrib><creatorcontrib>Bouloux, Pierre-Marc Gilles</creatorcontrib><creatorcontrib>Montgomery, Hugh</creatorcontrib><creatorcontrib>Baldeweg, Stephanie</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the Endocrine Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tzoulis, Ploutarchos</au><au>Waung, Julian</au><au>Bagkeris, Emmanouil</au><au>Hussein, Ziad</au><au>Biddanda, Aiyappa</au><au>Cousins, John</au><au>Dewsnip, Alice</au><au>Falayi, Kanoyin</au><au>McCaughran, P W</au><au>Mullins, Chloe</au><au>Naeem, Ammara</au><au>Nwokolo, Munachiso</au><au>Quah, Helen</au><au>Bitat, Syed Rabha</au><au>Deyab, Eithar</au><au>Ponnampalam, Swarupini</au><au>Bouloux, Pierre-Marc Gilles</au><au>Montgomery, Hugh</au><au>Baldeweg, Stephanie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Longitudinal Study of Prevalence of Sodium Abnormalities in Hospitalized Patients With COVID-19</atitle><jtitle>Journal of the Endocrine Society</jtitle><date>2021-05-03</date><risdate>2021</risdate><volume>5</volume><issue>Supplement_1</issue><spage>A630</spage><epage>A630</epage><pages>A630-A630</pages><issn>2472-1972</issn><eissn>2472-1972</eissn><abstract>Background: Sodium abnormalities (dysnatremia) are frequently observed in patients with community-acquired pneumonia and are associated with excess mortality. Data on the prevalence of hyponatremia and hypernatremia (serum sodium [Na] < 135 and > 145 mmol/L respectively) in patients with coronavirus disease 19 (COVID-19) are currently lacking. Methods: The aim of this study was to evaluate the prevalence and etiology of hyponatremia and hypernatremia at several timepoints during hospitalization of COVID-19 patients. This retrospective, longitudinal, observational study included all COVID-19 positive adult patients admitted to two London hospitals over an 8-week period (February to May 2020). Results: Clinic records were reviewed in 488 patients, 277 males (56.8%) and 211 females (43.2%), with a median age of 68 years. Comorbidities were documented in 79.6%, with the commonest being hypertension (45.7%), diabetes mellitus (25%), and chronic kidney disease (16.4%). Prior to admission, 25 patients (5.1%) had pre-existing chronic hyponatremia. At hospital presentation, median [Na] concentration was 137 mmol/L. Dysnatremia was present in 146 patients (29.9%), including 26 (5.3%) with hypernatremia and 120 (24.6%) with hyponatremia, of whom [Na] was 130-134 mmol/L in 90 (18.4%) and < 130 mmol/L in 30 (6.2%). Only 19% of patients with < 130 mmol/L underwent adequate laboratory assessment of the etiology of hyponatremia. Of those, based on a urinary sodium cut-off of 30 mmol/L, hyponatremia was classified as hypovolemia in 75% and non-hypovolemic in 25%. For the remaining hyponatremic cases, using 5 mmol/L as the cut-off value for plasma urea, 55.7% were classified as probable hypovolemic and 44.3% non-hypovolemic hyponatremia. There was an
upward trajectory of [Na] values during hospital stay with a median increase of 2 mmol/L in the first 48 hours following admission. On the fifth day of hospitalization, the prevalence was similar for hypernatremia and hyponatremia (13.8% and 14.1%, respectively). On the tenth day, hypernatremia was more common than hyponatremia (14.2% vs 10.2% respectively). Analysis of [Na] throughout the hospital stay defined four subgroups; 185 patients (37.9%) remained normonatremic throughout hospitalization; 180 (36.9%) had exposure to hyponatremia; 53 (10.9%) were exposed to hypernatremia; and 70 (14.3%) experienced both hypernatremia and hyponatremia. Conclusions: Hyponatremia, usually mild, was common at admission in Covid-19 positive patients, while hypovolemic hyponatremia appeared to be the predominant etiology. During hospital stay, abnormal sodium concentration was recorded in more than two thirds of Covid-19 positive patients. The association of dysnatremia with the outcomes in hospitalized COVID-19 patients warrants further exploration.</abstract><cop>US</cop><pub>Oxford University Press</pub><doi>10.1210/jendso/bvab048.1284</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2472-1972 |
ispartof | Journal of the Endocrine Society, 2021-05, Vol.5 (Supplement_1), p.A630-A630 |
issn | 2472-1972 2472-1972 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8090725 |
source | DOAJ Directory of Open Access Journals; Oxford Journals Open Access Collection; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Neuroendocrinology and Pituitary |
title | Longitudinal Study of Prevalence of Sodium Abnormalities in Hospitalized Patients With COVID-19 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A15%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Longitudinal%20Study%20of%20Prevalence%20of%20Sodium%20Abnormalities%20in%20Hospitalized%20Patients%20With%20COVID-19&rft.jtitle=Journal%20of%20the%20Endocrine%20Society&rft.au=Tzoulis,%20Ploutarchos&rft.date=2021-05-03&rft.volume=5&rft.issue=Supplement_1&rft.spage=A630&rft.epage=A630&rft.pages=A630-A630&rft.issn=2472-1972&rft.eissn=2472-1972&rft_id=info:doi/10.1210/jendso/bvab048.1284&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_8090725%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |